SE8204874L - Farmaceutiska preparat, innefattande humant insulin och humant proinsulin - Google Patents

Farmaceutiska preparat, innefattande humant insulin och humant proinsulin

Info

Publication number
SE8204874L
SE8204874L SE8204874A SE8204874A SE8204874L SE 8204874 L SE8204874 L SE 8204874L SE 8204874 A SE8204874 A SE 8204874A SE 8204874 A SE8204874 A SE 8204874A SE 8204874 L SE8204874 L SE 8204874L
Authority
SE
Sweden
Prior art keywords
proinsulin
human insulin
humant
pharmaceutical preparations
including human
Prior art date
Application number
SE8204874A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8204874D0 (sv
Inventor
R E Chance
B H Frank
J A Galloway
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE8204874D0 publication Critical patent/SE8204874D0/xx
Publication of SE8204874L publication Critical patent/SE8204874L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8204874A 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och humant proinsulin SE8204874L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671481A 1981-08-27 1981-08-27

Publications (2)

Publication Number Publication Date
SE8204874D0 SE8204874D0 (sv) 1982-08-25
SE8204874L true SE8204874L (sv) 1983-02-28

Family

ID=23143234

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204874A SE8204874L (sv) 1981-08-27 1982-08-25 Farmaceutiska preparat, innefattande humant insulin och humant proinsulin

Country Status (20)

Country Link
US (1) US4652547A (fr)
JP (1) JPS5846025A (fr)
AU (1) AU551733B2 (fr)
BE (1) BE894188A (fr)
CA (1) CA1176161A (fr)
CH (1) CH650678A5 (fr)
DE (1) DE3232033A1 (fr)
DO (1) DOP1982004086A (fr)
FR (1) FR2511867B1 (fr)
GB (1) GB2105191B (fr)
IL (1) IL66613A (fr)
IT (1) IT1153181B (fr)
LU (1) LU84356A1 (fr)
MW (1) MW4082A1 (fr)
NL (1) NL8203314A (fr)
NZ (1) NZ201686A (fr)
PH (1) PH18725A (fr)
SE (1) SE8204874L (fr)
ZA (1) ZA826158B (fr)
ZW (1) ZW17582A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DOP1982004086A (es) * 1981-08-27 1988-03-22 Lilly Co Eli Formula farmaceutica que comprende insulina humana y proinsulina humana
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
WO1990012091A1 (fr) * 1989-04-07 1990-10-18 Cancerforskningsfondet Af 1989 Recepteur de l'activateur du plasminogene du type urokinase
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
WO1997011959A1 (fr) * 1995-09-29 1997-04-03 Receptron, Inc. Peptides du cmh biologiquement actifs a motif repetitif de sequences d'acides amines
TR200400295T2 (tr) * 2001-05-21 2005-04-21 Nektar Therapeutics Kimyasal olarak modifiye edilmiş ensülin'in akçiğer yoluyla verilmesi
EP1429763B1 (fr) 2001-09-14 2007-05-30 Novo Nordisk A/S NOUVEAUX LIGANDS POUR LES SITES HisB10 Zn2+ D'HEXAMERES D'INSULINE EN R
US7670984B2 (en) * 2006-01-06 2010-03-02 Headwaters Technology Innovation, Llc Hydrocarbon-soluble molybdenum catalyst precursors and methods for making same
IL186598A0 (en) * 2007-10-11 2008-11-03 Mohammad Abdulrazik Composition and method for the treatment or prevention of glaucoma and ocular hypertension
US9939551B2 (en) 2012-09-24 2018-04-10 Schlumberger Technology Corporation Systems, devices and methods for borehole gravimetry
CN105073129A (zh) * 2013-01-29 2015-11-18 奥莎迪药品管理有限公司 用于糖尿病的口服治疗的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183849A (en) * 1975-01-15 1980-01-15 Nordisk Insulinlaboratorium Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
DOP1982004086A (es) * 1981-08-27 1988-03-22 Lilly Co Eli Formula farmaceutica que comprende insulina humana y proinsulina humana

Also Published As

Publication number Publication date
IL66613A (en) 1985-11-29
AU551733B2 (en) 1986-05-08
BE894188A (fr) 1983-02-24
LU84356A1 (fr) 1983-02-28
DOP1982004086A (es) 1988-03-22
US4652547A (en) 1987-03-24
NZ201686A (en) 1985-08-30
MW4082A1 (en) 1984-06-13
AU8759682A (en) 1983-03-03
IT8223016A0 (it) 1982-08-27
NL8203314A (nl) 1983-03-16
ZW17582A1 (en) 1982-11-17
FR2511867B1 (fr) 1986-08-14
FR2511867A1 (fr) 1983-03-04
GB2105191A (en) 1983-03-23
IT1153181B (it) 1987-01-14
PH18725A (en) 1985-09-11
IL66613A0 (en) 1982-12-31
CH650678A5 (de) 1985-08-15
DE3232033A1 (de) 1983-03-10
JPS5846025A (ja) 1983-03-17
CA1176161A (fr) 1984-10-16
GB2105191B (en) 1984-12-19
ZA826158B (en) 1984-04-25
SE8204874D0 (sv) 1982-08-25

Similar Documents

Publication Publication Date Title
SE8204874D0 (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
NO891379L (no) Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
YU135980A (en) Process for the manufacture of pharmaceutical formulations in the form of a polyacrylate film
EP0206291A3 (en) Sprayable pharmaceutical preparation for topical application
DK452289D0 (da) Praeparat eller system til behandling af diabetes
YU46023B (sh) Postupak za dobijanje novih analoga insulina
DK642587A (da) Insulinpraeparat
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
DK0518989T3 (da) Parasiticide præparater og fremgangsmåder til fremstilling og anvendelse deraf
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
GR3005612T3 (fr)
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
EP0009609A3 (fr) Adjuvant pour stimuler l'absorption de substances thérapeutiques actives par le tractus digestif, composition pharmaceutique contenant cet adjuvant et procédé pour la préparation de cette composition pharmaceutique; dérivés d'énamines
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
SE8204872D0 (sv) Farmaceutiska preparat, innefattande humant insulin, human c-peptid och humant proinsulin
JPS5569595A (en) Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
SE8704240D0 (sv) Analgesic preparations
ATE66375T1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
DE3879489D1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.